BRIEF published on 07/26/2024 at 07:05, 2 years 1 month ago BB Biotech AG Publishes Interim Report and Announces Leadership Change Investment Management Net Profit Interim Report Leadership Change BB Biotech
BRIEF published on 07/26/2024 at 07:05, 2 years 1 month ago BB Biotech AG publie un rapport intermédiaire et annonce un changement de direction Changement De Direction Bénéfice Net Gestion Des Investissements BB Biotechnologie Rapport Intérimaire
BRIEF published on 07/26/2024 at 07:05, 2 years 1 month ago Branicks Group AG: Successful New Lettings in Heidelberg's Bahnstadt District Real Estate Asset Management Branicks Group AG Office Space Leasing Stadttor Heidelberg
BRIEF published on 07/26/2024 at 07:05, 2 years 1 month ago Branicks Group AG : nouvelles locations réussies dans le quartier de Bahnstadt à Heidelberg Immobilier Branicks Group SA La Gestion D'actifs Stadttor Heidelberg Location De Bureaux
BRIEF published on 07/26/2024 at 07:05, 2 years 1 month ago LEM Reports Significant Sales Decline in Q1 2024/25 with Signs of Stabilization in China Financial Results Sales Decline LEM Q1 2024/25 China Stabilization
BRIEF published on 07/26/2024 at 07:05, 2 years 1 month ago LEM annonce une baisse significative de ses ventes au premier trimestre 2024/25 avec des signes de stabilisation en Chine Résultats Financiers Baisse Des Ventes LEM T1 2024/25 Stabilisation De La Chine
BRIEF published on 07/26/2024 at 07:05, 2 years 1 month ago Sunrise UPC GmbH Reports Continued Customer Growth and Solid Q2 Financial Results Financial Results Customer Satisfaction Spin-off Customer Growth Broadband Expansion
BRIEF published on 07/26/2024 at 07:05, 2 years 1 month ago Sunrise UPC GmbH annonce une croissance continue de sa clientèle et de solides résultats financiers au deuxième trimestre Résultats Financiers Satisfaction Du Client Croissance De La Clientèle Spin Off Expansion Du Haut Débit
BRIEF published on 07/26/2024 at 07:05, 2 years 1 month ago Significant Pipeline Progress at BB Biotech Offsets Market Volatility Portfolio Performance Market Volatility Biotech Sector Leadership Change BB Biotech
BRIEF published on 07/26/2024 at 07:05, 2 years 1 month ago Des progrès significatifs dans le pipeline chez BB Biotech compensent la volatilité du marché Changement De Direction Volatilité Du Marché Performance Du Portefeuille BB Biotechnologie Secteur Biotechnologique
Published on 09/12/2026 at 02:35, 14 hours 51 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 18 hours 26 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 19 hours 21 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 20 hours 1 minute ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 9 hours 56 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 19 hours 11 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 19 hours 16 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 21 hours 41 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 23 hours 11 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 10 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 10 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 21 hours ago Availability of the 2026 Interim Financial Report
